- Antibacterials
- Ebola Virus Disease
- Fungal Infections
- Hepatitis
- Herpes
- Infection Prevention & Control
- Infections
- Influenza
- MRSA
- Malaria
- Swine Flu
- Typhoid
Webcasts
- Antibiotic Combinations Role of ARBs
- Role of Fosfomycin IV in VAP, Sepsis and Bacterial Meningitis Patients
- CLSI 2020 Updates
- Judicious use of Antibiotics (2017)
- Common Errors in Antimicrobial Therapy
- Antibiotic Stewardship – A Must Do in the Era of Antibiotic Resistance (Panel Discussion)
- Judicious Use of Antibiotics (2016)
- MDR/XDR TB: A Case Based Approach with Panel Discussion
Expert's Viewpoint
- Experience Sharing of High Dose Minocycline by Infectious Disease Specialist
- Webinar Snippet: Can Minocycline be Used Against CRE and at What Dose?
- Webinar Snippet: Can Minocycline be Given as a Monotherapy?
- Webinar Snippet: Is Minocycline Safe to Use?
- Webinar Snippet: Does Minocycline Score Over Colistin?
- Webinar Snippet: Why Tigecycline Not Recommended in Blood Stream Infection?
- Webinar Snippet: Why High Dose Minocycline Should be Used?
Our Publications
Key Trials
- Ceftriaxone, Sulbactam and Disodium EDTA Combination Therapy Might Spare Carbapenems in Management of Multidrug Resistant Nosocomial Infections
- Efficacy of Daily Norfloxacin vs. Weekly Ciprofloxacin Prophylaxis for to Spontaneous Bacterial Peritonitis Prevention
- 3-day Treatment with Azithromycin (10 mg/kg per day once daily), A Promising Alternative Therapy for Tonsillitis in Children
- Prophylactic Antibiotics May Decrease Rate of Non-pancreatic Infection and UTI in Patients with Acute Pancreatitis
- Amoxicillin versus Amoxicillin-Clavulanate Prophylaxis in the Removal of Third Molars
- Efficacy and Safety of Oral Ciprofloxacin in Management of External Bacterial Otitis
- PROMISE Study: Moxifloxacin, Clinically and Bacteriologically Non-inferior to Ertapenem in Treatment of cIAIs
- Indian Prospective Study Comparing the Nephrotoxicity of Colistin and Polymyxin B Administered in Currently Recommended Doses
- TARGET Workshops Resources Improved Antibiotic Dispensing in Primary Care
- Efficacy and Safety of Moxifloxacin and Gatifloxacin as Initial TB Treatment
- ZEPHyR Study: Linezolid Superior to Vancomycin in Treatment of MRSA Nosocomial Pneumonia
- Prevalence of Methicillin-Resistant S. aureus Infection among Patients in the Emergency Department
Clinical Tools
Our Publications
Patient Education
Webcasts
- Art of Prescribing Antifungals
- Place in Therapy Of I.V Posaconzole In the Management of Invasive fungal infections in High-Risk Patients
- Dilemmas in the Management of Invasive Aspergillosis
- Empiric Therapy for Invasive Fungal Infections
- How Do I Treat Candida and Aspergillosis in the ICU
- Emerging Fungi in The ICU
- Prevalence, Diagnosis and Management of Differential Fungal Infections
- Update on Invasive Fungal Infections
- The 4 W’s of Antifungals: Why, Whom, Which and When
Our Publications
- Phosome IV (Liposomal Amphotericin B) Monograph
- Antimicrobial Spectrum Reckoner
- Caspogin I.V. (Caspofungin acetate) Data Sheet
- The Action of Phosome (Liposomal Amphotericin B)
- The Challenge of Creating Liposomal Amphotericin B
- The Search for a Magic Bullet
- Pocket Guide For Antimicrobial Dosing In Renal Failure
Conference Proceedings
Clinical Tools
Our Publications
- Approach to Hepatitis B in Pregnancy
- HCV Management Series: Management of Treatment-naïve and Treatment-experienced HCV Patients
- HCV: Epidemiology, Screening and Diagnosis
- Managing Treatment Response and Resistance in Hepatitis B
- Tenvir (Tenofovir disoproxil fumarate) - Product Monograph
- Practice Guidelines for Chronic Hepatitis B
- Principles of Hepatitis B Treatment
- Evaluating a Patient with Hepatitis B
Key Trials
- Efficacy and Safety of Tenofovir Alafenamide in Chronic Hepatitis B Infection
- Long Term Efficacy and Safety of Tenofovir in Chronic Hepatitis B infection
- Maternal Use of Tenofovir: No Additional Benefit in Lowering Perinatal HBV Transmission
- Sofosbuvir - Velpatasvir FDC for HCV Genotypes 1 to 6 Infection – Integrated Analyses of ASTRAL Studies
- Efficacy of Tenofovir Alone in Hepatitis B Patients with Suboptimal Virologic Response to Adefovir
- Tenofovir Benefits Patients with Severe Reactivation of Hepatitis B
- Tenofovir May be Highly Effective in Chronic Hepatitis B Patients Who Fail to Respond to Lamivudine and Adefovir Therapy
- Entecavir Lowers the Incidence of Hepatocellular Carcinoma in HBV Infected Patients
- Long Term Treatment with Tenofovir Might Result in Regression of Cirrhosis in Patients with Chronic Hepatitis B infection
Conference Proceedings
Patient Education
Guidelines
Our Publications
Webcasts
- A Case-based Discussion on Role of Fosfomycin IV in VAP and Sepsis
- Judicious use of Antibiotics (2017)
- Common Errors in Antimicrobial Therapy
- Judicious Use of Antibiotics (2016)
- Tropical Infections : A Case-based Approach
- Protecting Yourself (and your Patients) from Airborne Pathogens
- Drug Interactions – What Clinicians Need to Know?
- Vaccinations for Adults - What’s New, What Works?
- Pan Resistant Era: An SOS
- Infection Control in Health-Care Facilities: The Current Approach (Panel Discussion)
- If the Last Wall Falls…..The Need for Optimal use of Colistin
- Combating Influenza
- Optimizing the Use of Colistin in MDR Infections
Our Publications
Key Trials
Patient Education
Clinical Tools
Guidelines
- IAP Guidebook on Immunization (2018–2019)
- CDC: Guideline for Surgical Site Infection Prevention (2017)
- NCDC: National Treatment Guidelines for Antimicrobial Use in Infectious Diseases (2016)
- NCDC: National Risk Communication Plan (2016)
- CDC: Updated Zika Recommendations: Interim Guidance for the Prevention of Sexually Transmitted Zika Virus (July, 2016)
- NCDC/WHO: Indian Public Health Legislations (2015)
- NCDC: National Guidelines on Diagnosis Case Management and Prevention and Control of Leptospirosis (2015)
- WHO: Guideline on When to Start Antiretroviral Therapy and on Pre-exposure Prophylaxis for HIV (2015)
- CDC: Pre-exposure Prophylaxis for the Prevention of HIV Infection – 2014 : A Clinical Practice Guideline (2014)
Webcasts
- Management of Urinary Tract Infection in Women
- REMDESIVIR: Evidence to Experience
- Complicated UTI & Urosepsis: Uro- Physician Perspectives
- Antibiotic Combinations Role of ARBs
- A Case of Swine Flu ARDS
- Walking the Narrow Path: The Fine Line “Role of Fosfomycin IV in VAP, Sepsis and cUTI Patients
- Dealing with Complicated UTI to Urosepsis in the era of Antibiotic Resistance: Case based Discussion on role of Ceftriaxone Sulbactam EDTA
- Optimization of High Dose Minocycline in Current MDR / XDR Era
- A Case-based Discussion on Role of Fosfomycin IV in VAP and Sepsis
- The Fine Line: Role of Fosfomycin IV in VAP and Sepsis Patients
- Spot Sepsis
- Optimizing the use of Colistin in an Era of MDR Infections
- Managing Critically Ill Patients with Polymyxin B: A Case Based Discussion
- Place in Therapy Of I.V Posaconzole In the Management of Invasive fungal infections in High-Risk Patients
- Acute Otitis Media: Case Based Approach
- Urinary Tract Infection in Children : How do I Investigate?
- Colistin and Polymyxin B: Peas in a Pod, or Chalk and Cheese?
- Herpetic Keratitis
- Judicious use of Antibiotics (2017)
- Dilemmas in the Management of Invasive Aspergillosis
- Serious Infections and their Mimics: Reading between the Lines
- Sepsis and ARDS: Which is the Chicken and Which is the Egg?
- From Laboratory to Clinic: The Importance of Correlating the Culture Reports with the Clinical Case
- Prevalence, Diagnosis and Management of Differential Fungal Infections
- Tuberculosis Management in the Era of Drug Resistance
- BPH & Comorbidities
- TB: Back with a Vengeance (Panel Discussion)
- My Antibiotic Partner for Colistin
- Fluids in Septic Shock
- The 4 W’s of Antifungals: Why, Whom, Which and When
- Hit Plasmodia Before it Gets Complicated
- Principles and Interpretations of Laboratory Diagnostics for Malaria, Dengue, Typhoid and Tuberculosis
- Lacunae in the Management of TB
- MDR/XDR TB: A Case Based Approach with Panel Discussion
Expert's Viewpoint
Our Publications
- Cytorx (Flucytosine) Monograph
- Clarithromycin: An Emerging Treatment Recourse in Lower Respiratory Tract Infections
- Comprehensive Guide on the Use of Live Attenuated Influenza Vaccine (Nasovac-S)
- Zika Virus: A New Emerging Threat
- Guidance on Risk Categorization of Seasonal Influenza A H1N1 Cases during Screening
- Advisory for Vaccination and other Preventive Measures in Health Care Workers and General Public: Seasonal Influenza A (H1N1)
- Advisory for Families Staying and Travellers Visiting or Returning after Visiting Ebola-affected Countries
- Management of Ebola Virus Disease Patient in a Hospital
- An Overview of the Treatment Approaches Available for Ebola Virus Disease
- Summarized Clinical Practice Guidelines for the Diagnosis and Management of Group A Streptococcal Pharyngitis (Issue 2)
- H1N1: Guidance for Clinicians & Public Health Professionals
- H1N1: A Swine Flu Pandemic
Key Trials
- Efficacy and Safety of Remdesivir 5 Days Course verses 10 Days Course in Treatment of Patients with Severe Covid-19 Disease
- Ceftriaxone, Sulbactam and Disodium EDTA Combination Therapy Might Spare Carbapenems in Management of Multidrug Resistant Nosocomial Infections
- Efficacy of Daily Norfloxacin vs. Weekly Ciprofloxacin Prophylaxis for to Spontaneous Bacterial Peritonitis Prevention
- Tinidazole versus Metronidazole in Treatment of Amoebic Liver Abscess
- Remdesivir Shortens Time to Recovery in Patients Hospitalized with COVID-19
- Compassionate Use of Remdesivir to Treat Patients with Severe Covid-19
- Early Intervention with Remdesivir Associated with Clinical Improvement in Severe COVID-19 Patients
- Terbinafine versus Itraconazole in Treatment of Dermatophytic Infection of Skin
- Amoxicillin and Cefpodoxime Demonstrate Similar Clinical Efficacy in Children with Pneumonia
- Comparison of Standard-dose Versus High-dose of Amoxicillin/ Clavulanate for the Treatment of Clinically-diagnosed Acute Bacterial Sinusitis
- 3-day Treatment with Azithromycin (10 mg/kg per day once daily), A Promising Alternative Therapy for Tonsillitis in Children
- TANGO I Trial: Meropenem-Vaborbactam vs Piperacillin-Tazobactam for Treatment of Complicated Urinary Tract Infection
- Efficacy of Chlorhexidine in Reducing Oral Colonisation in the Geriatric Population
- Tigecycline Monotherapy vs. Imipenem/Cilastatin in Hospitalized Chinese Patients with cIAIs
- IDSA/ATS Guidelines Concerning Duration of Antibiotic Treatment Can be Safely Implemented Among Hospitalized Patients with CAP
- Amoxicillin versus Amoxicillin-Clavulanate Prophylaxis in the Removal of Third Molars
- Adjunctive Effect of the Metronidazole– Amoxicillin Antibiotic Combination in the Treatment of GAP
- Ibuprofen for Initial Symptomatic Treatment of Uncomplicated UTI
- Efficacy and Safety of Oral Ciprofloxacin in Management of External Bacterial Otitis
- PROMISE Study: Moxifloxacin, Clinically and Bacteriologically Non-inferior to Ertapenem in Treatment of cIAIs
- OSTRICH: A Short Course of Oral Steroid Treatment not Beneficial over Placebo for Treating Otitis Media with Effusion in Children
- BLISS Study: Continuous Administration of Beta-lactams Associated with Higher Clinical Cure Rates and Better PK/PD Target Attainment Compared to Intermittent Bolus Dosing
- Absence of Pyuria does not Rule out UTI in Children
Patient Education
Clinical Tools
- Patient Screening Questionnaire and Information for Health Care Professionals on Live Attenuated Influenza Vaccine (NASOVAC-S)
- CDC Recommendations for Pregnant Women during Zika Virus Outbreak
- Tracing and Reporting of Contacts for Ebola Virus Disease: Provisional Recommendations
- Ebola Virus Disease: Recommendations on Collection, Storage and Transportation of Samples from Suspected Cases
Guidelines
- ICMR: Treatment Guidelines for Antimicrobial Use in Common Syndromes (2019)
- IAP Guidebook on Immunization (2018–2019)
- AAP: Prevention and Control of influenza in Children (2017-2018)
- ACG Practice Guideline: Evaluation of Abnormal Liver Chemistries (2017)
- NCDC: National Treatment Guidelines for Antimicrobial Use in Infectious Diseases (2016)
- CDC: Updated Zika Recommendations: Interim Guidance for the Prevention of Sexually Transmitted Zika Virus (July, 2016)
- WHO: Guidelines for the Treatment of Malaria. Third Edition (2015)
- CDC: Guidelines for the Prevention of Intravascular Catheter-Related Infections (2011)
- IDSA: Clinical Practice Guidelines for the Management of Cryptococcal Disease (2010)
Our Publications
Key Trials
- Efficacy and Safety of Remdesivir 5 Days Course verses 10 Days Course in Treatment of Patients with Severe Covid-19 Disease
- Remdesivir Shortens Time to Recovery in Patients Hospitalized with COVID-19
- Compassionate Use of Remdesivir to Treat Patients with Severe Covid-19
- Early Intervention with Remdesivir Associated with Clinical Improvement in Severe COVID-19 Patients
Patient Education
Clinical Tools
Guidelines
Our Publications
Clinical Tools
- IDSA Recommendations: Management of Persistent MRSA Bacteremia and Vancomycin Treatment Failures
- IDSA Recommendations: Management of Recurrent MRSA Skin and Soft Tissue Infections
- IDSA Recommendations: Management of MRSA Bacteremia and Infective Endocarditis
- IDSA Recommendations: Management of MRSA Bone and Joint Infections
- IDSA Recommendations: Management of MRSA Infections of the Central Nervous System
- IDSA Recommendations: Management of MRSA Pneumonia
